|
KR100859972B1
(ko)
|
2006-02-20 |
2008-09-25 |
이화여자대학교 산학협력단 |
막투과 단백질 도메인 펩타이드
|
|
KR101169030B1
(ko)
*
|
2009-01-21 |
2012-07-26 |
애니젠 주식회사 |
신규한 세포막 투과 도메인 및 이를 포함하는 세포내 전달 시스템
|
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
RU2013120302A
(ru)
|
2010-10-01 |
2014-11-20 |
Модерна Терапьютикс, Инк. |
Сконструированные нуклеиновые кислоты и способы их применения
|
|
EP2691101A2
(en)
|
2011-03-31 |
2014-02-05 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
RU2648950C2
(ru)
|
2011-10-03 |
2018-04-02 |
Модерна Терапьютикс, Инк. |
Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
|
|
CN104114572A
(zh)
|
2011-12-16 |
2014-10-22 |
现代治疗公司 |
经修饰的核苷、核苷酸和核酸组合物
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
AU2013243948A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins associated with human disease
|
|
WO2013167298A1
(en)
|
2012-05-11 |
2013-11-14 |
Kael-Gemvax Co., Ltd. |
Anti-inflammatory peptides and composition comprising the same
|
|
JP6262721B2
(ja)
|
2012-05-11 |
2018-01-17 |
ジェムバックス アンド カエル カンパニー，リミティド |
敗血症の予防用または治療用の組成物
|
|
ES2981865T3
(es)
|
2012-07-11 |
2024-10-10 |
Gemvax & Kael Co Ltd |
Conjugado que comprende un péptido de penetración celular y composiciones que comprenden el mismo
|
|
JP6510410B2
(ja)
|
2012-09-19 |
2019-05-08 |
ジェムバックス アンド カエル カンパニー，リミティド |
細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物
|
|
ES2999332T3
(en)
|
2012-09-19 |
2025-02-25 |
Gemvax & Kael Co Ltd |
Cell penetrating peptide, conjugate comprising the same, and composition comprising conjugate
|
|
WO2014081507A1
(en)
|
2012-11-26 |
2014-05-30 |
Moderna Therapeutics, Inc. |
Terminally modified rna
|
|
KR101495417B1
(ko)
*
|
2013-01-31 |
2015-02-26 |
이화여자대학교 산학협력단 |
인슐린 점막 투과 개선용 조성물
|
|
EP2971010B1
(en)
|
2013-03-14 |
2020-06-10 |
ModernaTX, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
KR101595152B1
(ko)
*
|
2013-04-10 |
2016-02-17 |
이화여자대학교 산학협력단 |
Ｔｃｔｐ-ｐｔｄ를 포함하는 유전자 전달체
|
|
WO2014171792A1
(ko)
|
2013-04-19 |
2014-10-23 |
주식회사 카엘젬백스 |
허혈성 손상 치료 및 예방용 조성물
|
|
KR101491016B1
(ko)
*
|
2013-05-31 |
2015-02-10 |
건국대학교 산학협력단 |
배반포 및 생식기관 암 세포 특이적인 단백질 운반 방법 및 그 조성물
|
|
RU2677277C2
(ru)
|
2013-06-07 |
2019-01-16 |
Джемвакс Энд Каэл Ко., Лтд. |
Биологические маркеры, которые могут быть использованы в иммунотерапии рака
|
|
JP6495899B2
(ja)
|
2013-06-21 |
2019-04-03 |
ジェムバックス アンド カエル カンパニー，リミティド |
ホルモン分泌調節剤、及びそれを含む組成物
|
|
US20160194625A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
JP2016538829A
(ja)
|
2013-10-03 |
2016-12-15 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
低密度リポタンパク質受容体をコードするポリヌクレオチド
|
|
EP3061459B1
(en)
|
2013-10-23 |
2019-12-11 |
Gemvax & Kael Co., Ltd. |
Composition for treating and preventing benign prostatic hyperplasia
|
|
GB201318954D0
(en)
*
|
2013-10-28 |
2013-12-11 |
Cupid Peptide Company Ltd |
Cell transport
|
|
KR102359396B1
(ko)
|
2013-11-22 |
2022-02-08 |
주식회사 젬백스앤카엘 |
혈관 신생 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물
|
|
MY193287A
(en)
|
2013-12-13 |
2022-09-30 |
Basf Se |
Recombinant microorganism for improved production of fine chemicals
|
|
KR102314231B1
(ko)
|
2013-12-17 |
2021-10-19 |
주식회사 젬백스앤카엘 |
전립선 암 치료용 조성물
|
|
WO2015156649A1
(ko)
|
2014-04-11 |
2015-10-15 |
주식회사 젬백스앤카엘 |
섬유증 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물
|
|
JP6466971B2
(ja)
|
2014-04-30 |
2019-02-06 |
ジェムバックス アンド カエル カンパニー，リミティド |
臓器、組織又は細胞移植用組成物、キット及び移植方法
|
|
EP3613426A1
(en)
*
|
2014-05-21 |
2020-02-26 |
Entrada Therapeutics, Inc. |
Cell penetrating peptides and methods of making and using thereof
|
|
KR101804291B1
(ko)
|
2014-06-16 |
2018-01-10 |
이화여자대학교 산학협력단 |
TCTP 이량체형 IgE-의존성 히스타민 방출인자와 이의 수용체간의 결합을 억제하는 TCTP 유래 FL 도메인 및 이의 용도
|
|
WO2016014846A1
(en)
|
2014-07-23 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
KR102413243B1
(ko)
|
2014-12-23 |
2022-06-27 |
주식회사 젬백스앤카엘 |
안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
|
|
KR102636129B1
(ko)
|
2015-02-27 |
2024-02-14 |
주식회사 젬백스앤카엘 |
청력 손상 방어용 펩타이드 및 이를 포함하는 조성물
|
|
KR20250073577A
(ko)
|
2015-05-26 |
2025-05-27 |
주식회사 젬백스앤카엘 |
신규 펩티드 및 이를 포함한 조성물
|
|
KR102638286B1
(ko)
|
2015-07-02 |
2024-02-20 |
주식회사 젬백스앤카엘 |
항바이러스 활성 효능을 가지는 펩티드 및 이를 포함하는 조성물
|
|
KR101841241B1
(ko)
*
|
2015-09-10 |
2018-03-22 |
한양대학교 산학협력단 |
피부 질환에 대한 예방 또는 치료효과를 갖는 펩티드 융합체 및 이를 유효성분으로 하는 약학 조성물
|
|
CA3003156C
(en)
|
2015-11-06 |
2023-12-05 |
Terry Vanden Hoek |
Peptides and method for treatment of cardiac arrest
|
|
JP7341451B2
(ja)
|
2016-02-01 |
2023-09-11 |
エピアクシス セラピューティクス プロプライアタリー リミティド |
タンパク質性化合物とその利用
|
|
WO2017176076A1
(en)
|
2016-04-06 |
2017-10-12 |
Ewha University - Industry Collaboration Foundation |
A peptide with ability to penetrate cell membrane
|
|
EP3440096A4
(en)
*
|
2016-04-06 |
2019-11-13 |
Ewha University-Industry Collaboration Foundation |
PEPTIDE WITH ABILITY TO CELL MEMBRANE PENETRATION
|
|
US10898540B2
(en)
|
2016-04-07 |
2021-01-26 |
Gem Vax & KAEL Co., Ltd. |
Peptide having effects of increasing telomerase activity and extending telomere, and composition containing same
|
|
EP3556766B1
(en)
*
|
2016-12-16 |
2024-07-31 |
Avixgen Inc. |
Use of a cell membrane penetrating peptide and intracellular delivery carrier including the same
|
|
JP7285220B2
(ja)
|
2017-05-18 |
2023-06-01 |
モデルナティエックス インコーポレイテッド |
連結したインターロイキン－１２（ｉｌ１２）ポリペプチドをコードするポリヌクレオチドを含む脂質ナノ粒子
|
|
WO2018213789A1
(en)
|
2017-05-18 |
2018-11-22 |
Modernatx, Inc. |
Modified messenger rna comprising functional rna elements
|
|
EP3638292A1
(en)
|
2017-06-14 |
2020-04-22 |
ModernaTX, Inc. |
Polynucleotides encoding coagulation factor viii
|
|
SG10202110492YA
(en)
|
2017-06-22 |
2021-11-29 |
Catalyst Biosciences Inc |
Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use
|
|
JP2020531514A
(ja)
|
2017-08-22 |
2020-11-05 |
モナシュ・ユニヴァーシティ |
終末糖化産物受容体（ｒａｇｅ）の活性化のスクリーニングアッセイ、モジュレーター及び調節
|
|
WO2019090390A1
(en)
|
2017-11-08 |
2019-05-16 |
University Of Canberra |
Immunogenic compositions and uses therefor
|
|
US20220265856A1
(en)
|
2017-11-22 |
2022-08-25 |
Modernatx, Inc. |
Polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits for the treatment of propionic acidemia
|
|
EP3714048B1
(en)
|
2017-11-22 |
2025-04-09 |
ModernaTX, Inc. |
Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
|
|
JP7423521B2
(ja)
|
2017-11-22 |
2024-01-29 |
モダーナティエックス・インコーポレイテッド |
フェニルケトン尿症の治療用のフェニルアラニンヒドロキシラーゼをコードするポリヌクレオチド
|
|
KR101933217B1
(ko)
|
2017-12-28 |
2018-12-27 |
(주) 에빅스젠 |
피부 염증 억제용 펩티드 및 이를 포함하는 피부 염증 예방 또는 치료용 조성물
|
|
MA51523A
(fr)
|
2018-01-05 |
2020-11-11 |
Modernatx Inc |
Polynucléotides codant pour des anticorps anti-virus du chikungunya
|
|
EP3790890A4
(en)
|
2018-05-09 |
2022-03-02 |
Ohio State Innovation Foundation |
CYCLIC, CELL-PENETRATING PEPTIDES WITH ONE OR MORE HYDROPHOBIC RAILS
|
|
WO2019226650A1
(en)
|
2018-05-23 |
2019-11-28 |
Modernatx, Inc. |
Delivery of dna
|
|
US20220184185A1
(en)
|
2018-07-25 |
2022-06-16 |
Modernatx, Inc. |
Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders
|
|
US10842827B2
(en)
*
|
2018-08-22 |
2020-11-24 |
José Manuel Aguilar Yáñez |
Treatment and compound for epithelial wounds
|
|
WO2020047201A1
(en)
|
2018-09-02 |
2020-03-05 |
Modernatx, Inc. |
Polynucleotides encoding very long-chain acyl-coa dehydrogenase for the treatment of very long-chain acyl-coa dehydrogenase deficiency
|
|
WO2020056147A2
(en)
|
2018-09-13 |
2020-03-19 |
Modernatx, Inc. |
Polynucleotides encoding glucose-6-phosphatase for the treatment of glycogen storage disease
|
|
US20220243182A1
(en)
|
2018-09-13 |
2022-08-04 |
Modernatx, Inc. |
Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex e1-alpha, e1-beta, and e2 subunits for the treatment of maple syrup urine disease
|
|
WO2020056239A1
(en)
|
2018-09-14 |
2020-03-19 |
Modernatx, Inc. |
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
|
|
EP3856233A1
(en)
|
2018-09-27 |
2021-08-04 |
Modernatx, Inc. |
Polynucleotides encoding arginase 1 for the treatment of arginase deficiency
|
|
US11613744B2
(en)
|
2018-12-28 |
2023-03-28 |
Vertex Pharmaceuticals Incorporated |
Modified urokinase-type plasminogen activator polypeptides and methods of use
|
|
CA3176021A1
(en)
|
2018-12-28 |
2020-07-02 |
Catalyst Biosciences, Inc. |
Modified urokinase-type plasminogen activator polypeptides and methods of use
|
|
CA3128615A1
(en)
|
2019-03-01 |
2020-09-10 |
Flagship Pioneering Innovations Vi, Llc |
Topical delivery of polyribonucleic acids
|
|
MA55083A
(fr)
|
2019-03-01 |
2022-03-16 |
Flagship Pioneering Innovations Vi Llc |
Polyribonucléotides et leurs utilisations cosmétiques
|
|
JP2022532078A
(ja)
|
2019-05-08 |
2022-07-13 |
アストラゼネカ アクチボラグ |
皮膚及び創傷のための組成物並びにその使用の方法
|
|
CN112694522B
(zh)
*
|
2020-03-11 |
2022-06-14 |
浙江大学 |
一种基于GluN2A亚基的细胞穿膜肽及其应用
|
|
KR102274999B1
(ko)
*
|
2020-04-23 |
2021-07-08 |
주식회사 아임뉴런바이오사이언스 |
신규한 세포 투과성 펩타이드 및 이의 용도
|
|
IL298363A
(en)
|
2020-05-20 |
2023-01-01 |
Flagship Pioneering Innovations Vi Llc |
Immunogenic compositions and uses thereof
|
|
US20230235298A1
(en)
|
2020-06-01 |
2023-07-27 |
Modernatx, Inc. |
Phenylalanine hydroxylase variants and uses thereof
|
|
MX2023002439A
(es)
|
2020-09-03 |
2023-05-09 |
Flagship Pioneering Innovations Vi Llc |
Composiciones immunogénicas y usos de las mismas.
|
|
AU2021377895A1
(en)
|
2020-11-13 |
2023-06-15 |
Modernatx, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
KR20220085522A
(ko)
*
|
2020-12-15 |
2022-06-22 |
주식회사 아이큐어비앤피 |
세포막 투과성을 갖는 신규 펩타이드
|
|
WO2022204371A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereof
|
|
WO2022204369A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia
|
|
US20240216288A1
(en)
|
2021-03-24 |
2024-07-04 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof
|
|
US20240207444A1
(en)
|
2021-03-24 |
2024-06-27 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereof
|
|
WO2022204370A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding ornithine transcarbamylase for the treatment of ornithine transcarbamylase deficiency
|
|
KR20220157778A
(ko)
*
|
2021-05-21 |
2022-11-29 |
원큐어젠 주식회사 |
세포 투과성 펩타이드 및 글루카곤 유사 펩타이드-1 수용체 작용제를 포함하는 복합체
|
|
EP4355882A2
(en)
|
2021-06-15 |
2024-04-24 |
Modernatx, Inc. |
Engineered polynucleotides for cell-type or microenvironment-specific expression
|
|
WO2022271776A1
(en)
|
2021-06-22 |
2022-12-29 |
Modernatx, Inc. |
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
|
|
US20250017867A1
(en)
|
2021-10-01 |
2025-01-16 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
|
|
WO2023063759A1
(ko)
*
|
2021-10-13 |
2023-04-20 |
(주) 캠프테라퓨틱스 |
나노몰 농도에서 세포 내 전달 가능한 미토콘드리아 특이적 펩타이드 및 이의 용도
|
|
KR20230061895A
(ko)
*
|
2021-10-29 |
2023-05-09 |
주식회사 아이큐어비앤피 |
지질 나노입자 및 세포 투과성을 갖는 신규 펩타이드의 복합체
|
|
WO2023183909A2
(en)
|
2022-03-25 |
2023-09-28 |
Modernatx, Inc. |
Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemia
|
|
US20260035707A1
(en)
|
2022-07-26 |
2026-02-05 |
Modernatx, Inc. |
Engineered polynucleotides for temporal control of expression
|
|
WO2024117321A1
(ko)
*
|
2022-12-01 |
2024-06-06 |
㈜에빅스젠 |
세포막 투과 펩티드 및 이를 포함하는 세포내 전달체
|
|
WO2024197033A1
(en)
|
2023-03-21 |
2024-09-26 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of heart failure
|
|
EP4704816A1
(en)
|
2023-05-03 |
2026-03-11 |
ModernaTX, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
WO2025009503A1
(ja)
*
|
2023-07-03 |
2025-01-09 |
メスキュージェナシス株式会社 |
細胞膜透過性を有するペプチドおよびそのスクリーニング方法
|
|
WO2025072482A1
(en)
|
2023-09-27 |
2025-04-03 |
Modernatx, Inc. |
Immunoglobulin a protease polypeptides, polynucleotides, and uses thereof
|
|
WO2025255199A1
(en)
|
2024-06-05 |
2025-12-11 |
Modernatx, Inc. |
Argininosuccinate synthase 1 and argininosuccinate lyase polypeptides and polynucleotides and uses thereof
|